Product Description
Concentration
Total: 70 mg per vial
10 mg BPC-157
10 mg TB-500
50 mg GHK-Cu
Physical Form
Blue-white lyophilized powder in a sterile vial
Product Features
Triple-peptide blend freeze-dried for optimal stability
Butyl rubber stopper allows multiple punctures while maintaining sterility
Vials are depyrogenated, ETO-sterilized, and sealed with a tamper-evident aluminum flip-top
Research Highlights
Comprehensive Wound Repair
BPC-157 accelerates fibroblast migration and collagen deposition
TB-500 drives angiogenesis and actin-mediated tissue remodeling
GHK-Cu tightens skin, stimulates ECM turnover, and recruits immune cells
Muscle & Tendon Recovery
Synergistic effects support faster healing of ligaments, tendons, and muscle fibers while reducing inflammation and oxidative stress.
Skin Rejuvenation & Anti-Aging
GHK-Cu boosts elastin and collagen synthesis, improving firmness, tone, and scar appearance; BPC-157 counters free-radical damage.
Vascular & Circulatory Support
TB-500 promotes endothelial cell differentiation and new capillary formation; BPC-157 enhances collateral blood-vessel growth in ischemic tissue.
Neuro- & Immuno-Modulation
GHK-Cu shows neuroprotective and antimicrobial properties; BPC-157 modulates nitric-oxide pathways, supporting balanced immune responses.
Important Terms
For research use only (RUO). Not intended for human consumption or for use in medical, veterinary, or household applications. By purchasing this product, you agree to comply with all stated Terms & Conditions.
GLOW BLEND (BPC-157, TB-500, and GHK-Cu) 70mg
GLOW (70 mg Vial) dosage protocol is designed to support regenerative processes and assist in tissue repair through daily or split-week subcutaneous or intramuscular injections.
Combines GHK-Cu, TB-500, and BPC-157 in one vial
Typical doses range from 2 mg to 5 mg daily (standard)
Higher 10 mg doses (advanced) for short-term intense support
Reconstitute with up to 3 mL for accurate syringe measurements
Store lyophilized in a cool, dry place; refrigerate post-reconstitution
Dosing & Reconstitution Guide
Educational guide for reconstitution and dosing protocol
Standard / Gradual Approach (3 mL = ~23.3 mg/mL)
PHASE
DAILY DOSE
APPROX. UNITS (PER INJECTION)
Weeks 1–4
2 mg (2000 mcg)
~9 units (0.09 mL)
Weeks 5–8
5 mg (5000 mcg)
~20 units (0.20 mL)
Ideal for most daily (or 3x/week) usage. Reconstitute with 3 mL of bacteriostatic water, creating ~23.3 mg/mL. Each “unit” on a 1 mL insulin syringe is ~0.233 mg of the blend.
Draw 3.0 mL of bacteriostatic water into a sterile syringe.
Inject the water slowly along the vial wall to minimize foam/froth.
Gently swirl—avoid vigorous shaking.
Store reconstituted vial in the refrigerator (2–8°C).
Advanced / Aggressive Approach (3 mL = ~23.3 mg/mL)
PHASE
DAILY DOSE
APPROX. UNITS (PER INJECTION)
Weeks 1–2 (Intensive)
10 mg (10000 mcg)
~43 units (0.43 mL)
Weeks 3–6
5 mg (5000 mcg)
~20 units (0.20 mL)
Recommended for severe or acute cases needing higher initial doses. Reconstitute similarly with 3 mL to maintain an easy measurement (~23.3 mg/mL). If <10 units is required, consider smaller syringes, but typically 10 mg is ~43 units—still under 60 units.
Inject 3.0 mL of bacteriostatic water slowly into the vial.
Roll/swirl gently to dissolve the powder completely.
Refrigerate and label the vial with the date of mixing.
After 2 weeks, reduce to 5 mg daily or scale dosing as needed.
Avoid multiple freeze-thaw cycles and protect from light.